featured news

December 8, 2025

Berger Montague PC Investigating Claims on Behalf of StubHub Holdings, Inc. (NYSE: STUB) Investors After Class Action Filing

December 3, 2025

Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing

December 2, 2025

Berger Montague Announces Launch of the “AAI Appellate Project”: A Hub for Pro-Enforcement Antitrust Appellate Advocacy

February 20, 2013 General

Will Final Rule for Sunshine Act Decrease Medical Fraud?

On Friday, February 1, 2013, the Centers for Medicare and Medicaid Services (CMS) published a long-delayed final rule for the Physician Payments Sunshine Act. The Sunshine Act requires all drug, medical device, and biological or medical supply manufacturers to carefully track and report all payments made to physicians and teaching hospitals. […]

#Kickback Laws #Medical Fraud

Contact UsFree Case Evaluation

"*" indicates required fields

First Name*

Last Name*

Email Address*

Phone Number*

Practice Area

City*

State*

Please describe your potential case or matter.**

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.

featured investigations

StubHub Securities Fraud Investigation

Investigation Deadline: January 23, 2026

Under Investigation
Securities Fraud & Investor Protection

A class action lawsuit has been filed against StubHub Holdings, Inc. (NYSE: STUB) on behalf of investors who purchased or otherwise acquired StubHub securities during the period of September 14, 2025...

join the case

In re Construction Equipment Rental Antitrust Litigation

Antitrust

Berger Montague and DiCello Levitt are co-lead counsel in an antitrust lawsuit to combat an unlawful cartel that is raising construction equipment rental prices nationwide. The lawsuit alleges that...

join the case

Skye Bioscience Securities Fraud Investigation

Investigation Deadline: January 16, 2026

Status: Pending
Under Investigation
Securities Fraud & Investor Protection

A class action lawsuit has been filed against Skye Bioscience, Inc. (NASDAQ: SKYE) on behalf of investors who purchased or otherwise acquired Skye securities during the period of November 4, 2024...

join the case

$2.4B+

in 2025 post-trial judgments

$50B+

in Settlements & Verdicts

55+

Years of Experience With High-Profile Cases

100+

Attorneys Protecting Your Rights

20+

Years Ranked as Top Law Firm by Chambers USA

States in Which The Firm Has Successfully Litigated